RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.86B
AUM Growth
+$1.46B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
83
New
Increased
Reduced
Closed

Top Buys

1
+$163M
2
+$141M
3
+$105M
4
LENZ
LENZ Therapeutics
LENZ
+$93.3M
5
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
+$71M

Top Sells

1
+$704M
2
+$164M
3
+$94M
4
ALPN
Alpine Immune Sciences Inc
ALPN
+$93.6M
5
INBX
Inhibrx, Inc. Common Stock
INBX
+$73.2M

Sector Composition

1 Healthcare 99.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$1.53B 19.44%
10,108,400
+1,000
2
$560M 7.13%
8,203,754
+312,500
3
$385M 4.9%
6,861,097
+596,390
4
$345M 4.39%
9,165,652
5
$244M 3.11%
236,114
6
$231M 2.94%
5,330,412
7
$188M 2.39%
5,736,132
+3,187,000
8
$186M 2.37%
7,864,000
9
$178M 2.26%
3,442,825
+38,540
10
$171M 2.17%
10,416,609
+3,180,155
11
$163M 2.07%
+8,909,091
12
$161M 2.05%
5,051,511
+888,300
13
$160M 2.03%
740,727
+207,835
14
$157M 2%
10,689,545
+2,557,593
15
$152M 1.94%
46,202,425
16
$149M 1.89%
12,766,948
+1,350,000
17
$141M 1.79%
+4,954,779
18
$131M 1.67%
1,977,901
19
$129M 1.64%
7,809,852
20
$117M 1.49%
10,805,129
+3,000,000
21
$112M 1.43%
18,202,009
22
$111M 1.41%
10,860,977
+1,401,299
23
$110M 1.39%
11,609,704
24
$102M 1.29%
6,317,990
25
$93.3M 1.19%
+4,178,823
1
2 3 4